CymaBay Therapeutics Inc.

10/23/2023 | Press release | Distributed by Public on 10/23/2023 16:13

Seladelpar Treatment Resulted in Correlated Decreases in Serum IL-31 and Pruritus in Patients with Primary Biliary Cholangitis (PBC)